|
|
immune effector process
|
GO:0002252 |
321 |
0.205
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.189
|
|
|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
0.147
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.127
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.121
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.118
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.117
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.114
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.113
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.112
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.112
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.110
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.102
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.098
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.094
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.085
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.078
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.074
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.073
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.071
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.070
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.065
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.065
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.063
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.062
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.062
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.061
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.061
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.060
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.059
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.055
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.055
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.054
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.053
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.052
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.051
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.051
|
|
|
|
diterpenoid biosynthetic process
|
GO:0016102 |
7 |
0.050
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.050
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.049
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.048
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.048
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.047
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.047
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.047
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.046
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.046
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.045
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.045
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.044
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.044
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.044
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.043
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.043
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.043
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.043
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.042
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.042
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.042
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.042
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.042
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.042
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.041
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.040
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.040
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.040
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.040
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.039
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.039
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.039
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.039
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.038
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.038
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.038
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.038
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.038
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.038
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.037
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.037
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.037
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.036
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.036
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.036
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.036
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.036
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.035
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.035
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.035
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.035
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.035
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.035
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.035
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.035
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.035
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.035
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.035
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.034
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.034
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.034
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.034
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.034
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.034
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.033
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.033
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.033
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.032
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.032
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.032
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.032
|
|
|
|
terpenoid biosynthetic process
|
GO:0016114 |
7 |
0.031
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.031
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.031
|
|
|
|
lipid digestion
|
GO:0044241 |
7 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.030
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.030
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.030
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.030
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.030
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.030
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.030
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.030
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.030
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.030
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.030
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.030
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.030
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.029
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.029
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.029
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.029
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.029
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.028
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.028
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.028
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.028
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.028
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.028
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.028
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.028
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.028
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.027
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.027
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.027
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.027
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.027
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.027
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.027
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.027
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.027
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.027
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.027
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.027
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.026
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.026
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.026
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.026
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.026
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.026
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.026
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.026
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.026
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.025
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.025
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.025
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.025
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.025
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.024
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.024
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.024
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.024
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.024
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.023
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.023
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.023
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.023
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.023
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.023
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.023
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.023
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.023
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.023
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.023
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.023
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.023
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.023
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.023
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.022
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.022
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.022
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.022
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.022
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.022
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.022
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.022
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.022
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.022
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.022
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.022
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.022
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.022
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.022
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.022
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.022
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.021
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.021
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.021
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.021
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.021
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.021
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.021
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.021
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.020
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.020
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.020
|
|
|
|
drug transmembrane transport
|
GO:0006855 |
5 |
0.020
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.020
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.020
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.020
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.020
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.020
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.020
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.019
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.019
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.019
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.019
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.019
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.019
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.019
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.019
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.019
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.019
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.019
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.019
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.019
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.019
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.019
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.019
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.019
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.019
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.019
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.019
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.019
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.018
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.018
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.018
|
|
|
|
drug transport
|
GO:0015893 |
7 |
0.018
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.018
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.018
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.018
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.018
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.018
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.018
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.018
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.018
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.018
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.018
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.018
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.017
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.017
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.017
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.017
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.017
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.017
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.017
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.017
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.017
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.017
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.017
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.017
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.017
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.017
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.017
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.017
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.017
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.017
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.017
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.017
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.016
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.016
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.016
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
isoprenoid biosynthetic process
|
GO:0008299 |
9 |
0.016
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.016
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.016
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.016
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.016
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.016
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.016
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.016
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.016
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.016
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.016
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.016
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.016
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.016
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.016
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.016
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.016
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.016
|
|
|
|
regulation of toll like receptor 2 signaling pathway
|
GO:0034135 |
3 |
0.016
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.016
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.016
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.016
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.015
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.015
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.015
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.015
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.015
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.015
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.015
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
dopamine catabolic process
|
GO:0042420 |
4 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.015
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.015
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.015
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.015
|
|
|
|
acyl coa metabolic process
|
GO:0006637 |
19 |
0.015
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.015
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.015
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.015
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.015
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.015
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.015
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.015
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.015
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.015
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.015
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.014
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.014
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.014
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.014
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.014
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.014
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.014
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.014
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.014
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.014
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.014
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.014
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.014
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.014
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.014
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
|
cellular divalent inorganic anion homeostasis
|
GO:0072501 |
3 |
0.014
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.014
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.014
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.014
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.014
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.014
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.014
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.014
|
|
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.014
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.014
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.014
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.014
|
|
|
|
interleukin 18 production
|
GO:0032621 |
4 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.014
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.013
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.013
|
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.013
|
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.013
|
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.013
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.013
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.013
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.013
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.013
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.013
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.013
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.013
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.013
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.013
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.013
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.013
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.013
|
|
|
|
alpha amino acid catabolic process
|
GO:1901606 |
18 |
0.013
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.013
|
|
